시장보고서
상품코드
1797022

세계의 생물 안전 캐비닛 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)

Biological Safety Cabinet Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type, By End User, By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 생물 안전 캐비닛 시장은 2024년에는 2억 8,726만 달러로 평가되었고, 예측 기간 동안 CAGR 8.00%로 성장할 전망이며, 2030년에는 4억 5,587만 달러에 달할 것으로 예측됩니다.

세계의 생물 안전 캐비닛 시장은 전염병 위험이 증가하고 생명공학 및 제약 기업에서 연구개발 활동이 활발해짐에 따라 큰 성장을 이루고 있습니다. 생물 안전 캐비닛은 바이오 안전 캐비닛으로도 알려져 있습니다. 이것은 병원체에 오염된 요소를 안전하게 취급할 수 있게 하는 폐쇄된 환기 작업 공간이며, 지정된 생물 안전 레벨을 필요로 합니다. 시장 성장을 지원하는 다른 요인으로는 만성 질환 치료를 위한 개인화된 의료에 대한 수요가 증가하고 만성 질환이 있는 고령화 인구 증가가 포함됩니다. 또한 의료 분야에서의 연구개발 활동의 활성화 및 다양한 신기술의 채용이 증가하고 있는 것도 시장 성장의 요인이 되고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모(2024년) 2억 8,726만 달러
시장 규모(2030년) 4억 5,587만 달러
CAGR(2025-2030년) 8.00%
급성장 부문 진단 및 검사실
최대 시장 북미

시장 성장 촉진요인

병원체 조사에서 실험실의 생물 안전 의식 증가

주요 시장 과제

높은 초기 비용 및 운영 비용

주요 시장 동향

스마트하고 에너지 효율적인 BSC 설계 혁신

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 생물 안전 캐비닛 시장 전망

  • 시장 규모 및 예측
    • 금액별
  • 시장 점유율 및 예측
    • 유형별(클래스 I, 클래스 II, 클래스 III)
    • 최종 사용자별(제약 및 바이오 의약품 기업, 진단 및 검사기관, 학술기관 및 연구기관)
    • 지역별
    • 기업별(2024년)
  • 시장 맵
    • 유형별
    • 최종 사용자별
    • 지역별

제6장 북미의 생물 안전 캐비닛 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 생물 안전 캐비닛 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 생물 안전 캐비닛 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 생물 안전 캐비닛 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 생물 안전 캐비닛 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향 및 발전

  • 최근 동향
  • 제품 출시
  • 합병 및 인수

제13장 Porter's Five Forces 분석

  • 업계 내 경쟁
  • 신규 진입의 가능성
  • 공급자의 힘
  • 고객의 힘
  • 대체품의 위협 및 서비스

제14장 세계의 생물 안전 캐비닛 시장 : SWOT 분석

제15장 경쟁 구도

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical(Qingdao Biomedical Co., Ltd.)
  • Cruma SA
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

제16장 전략적 제안

제17장 기업 소개 및 면책사항

AJY 25.08.29

Global Biological Safety Cabinet Market was valued at USD 287.26 million in 2024 and is expected to reach USD 455.87 million by 2030 with a CAGR of 8.00% during the forecast period. The global market for Biological Safety Cabinet is experiencing significant growth, driven by the rising risk of communicable diseases and increasing research and development activities in biotechnology and pharmaceutical companies. Biological Safety Cabinets is also known as biosafety cabinets. It is an enclosed ventilated workspace that enables safety working with elements contaminated with pathogens, which requires a designated biosafety level. The other factors supporting the market's growth are the growing demand for personalized medicine for the treatment of chronic diseases, and the growing aging population with chronic diseases. Moreover, the rise in the research and development activities in the medical sector and the rise in the adoption of various new technologies are the contributing factors to the growth of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 287.26 Million
Market Size 2030USD 455.87 Million
CAGR 2025-20308.00%
Fastest Growing SegmentDiagnostics & Testing Laboratories
Largest MarketNorth America

Key Market Drivers

Escalating Awareness of Lab Biosafety in Pathogen Research

The recent focus on high-risk pathogen handling-especially following outbreaks such as COVID 19, Ebola, and anthrax lapses-has catalyzed a global push towards safer laboratory environments. Biosafety cabinets are central to these efforts, offering primary containment to reduce staff exposure and environmental pollution. In the United States, repeated audits by the CDC and Department of Health have highlighted biosafety lapses, prompting reforms and procedural overhauls. International bodies such as the World Health Organization (WHO) also stress strict biosafety practices. For example, in 2023 WHO supported certification training in Nepal to strengthen national biosafety capacity. As pandemic preparedness becomes a policy priority, national health agencies are investing in BSCs-especially Class II and III-to ensure safe handling of emerging pathogens. Such measures align with recommended biosafety upgrade plans and global health compliance frameworks, boosting BSC market demand.

Key Market Challenges

High Initial and Operational Costs

Despite regulatory backing, cost remains a barrier for many laboratories. Advanced Class II and III units-with HEPA filters, air handling ducting, and smart electronics-can be prohibitively expensive, especially in resource-limited settings. Even after purchase, recurring costs related to HEPA filter replacements, airflow testing equipment, and annual NSF/ANSI certifications add up.

Improper or inadequate installation, lack of trained personnel, and budget constraints can reduce compliance. As noted in Southeast Asian labs, ~30% of BSCs were found to be mis installed or improperly maintained. Without sustained funding, especially in low-income institutions, these safety-critical systems may lapse into disuse or underperformance-posing regulatory and biohazard risks.

Key Market Trends

Innovation in Smart, Energy-Efficient BSC Designs

A major ongoing trend is the rise of smart, energy-efficient biosafety cabinets. Manufacturers are integrating digital airflow monitoring, automated sash control, and IoT-enabled alerts for filter replacement or airflow disruptions. Some advanced models self-adjust airflow when idle, reducing energy usage by up to 30%, along with LED lighting and efficient motors that further cut operating costs.

Cabinets designed to fit in space-constrained microbiology or pharmaceutical labs-often with laminar and containment airflow modes-are gaining popularity. These smart and sustainable innovations align with institutional goals to improve safety while minimizing carbon footprint and operational expense, signaling a shift toward eco-conscious laboratory design.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • Cruma S.A.
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

Report Scope:

In this report, the Global Biological Safety Cabinet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Safety Cabinet Market, By Type:

  • Class I
  • Class II
  • Class III

Biological Safety Cabinet Market, By End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostics & Testing Laboratories
  • Academic & Research Organizations

Biological Safety Cabinet Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biological Safety Cabinet Market.

Available Customizations:

Global Biological Safety Cabinet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Safety Cabinet Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Class I, Class II, Class III)
    • 5.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. North America Biological Safety Cabinet Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Class I, Class II, Class III)
    • 6.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biological Safety Cabinet Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Biological Safety Cabinet Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Biological Safety Cabinet Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Biological Safety Cabinet Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Class I, Class II, Class III)
    • 7.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Biological Safety Cabinet Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Biological Safety Cabinet Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Biological Safety Cabinet Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Biological Safety Cabinet Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Biological Safety Cabinet Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Biological Safety Cabinet Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Class I, Class II, Class III)
    • 8.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biological Safety Cabinet Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Biological Safety Cabinet Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Biological Safety Cabinet Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Biological Safety Cabinet Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Biological Safety Cabinet Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. South America Biological Safety Cabinet Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Class I, Class II, Class III)
    • 9.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biological Safety Cabinet Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Biological Safety Cabinet Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Biological Safety Cabinet Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Biological Safety Cabinet Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Class I, Class II, Class III)
    • 10.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biological Safety Cabinet Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Biological Safety Cabinet Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Biological Safety Cabinet Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Global Biological Safety Cabinet Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Labconco Corp.
  • 15.3. NuAire, Inc.
  • 15.4. The Baker Company, Inc.
  • 15.5. Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • 15.6. Cruma S.A.
  • 15.7. Jinan Biobase Biotech Co. Ltd.
  • 15.8. Azbil Telstar
  • 15.9. Germfree Laboratories, Inc.
  • 15.10. Air Science, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제